CN113004216B - Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe - Google Patents
Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe Download PDFInfo
- Publication number
- CN113004216B CN113004216B CN201911322539.8A CN201911322539A CN113004216B CN 113004216 B CN113004216 B CN 113004216B CN 201911322539 A CN201911322539 A CN 201911322539A CN 113004216 B CN113004216 B CN 113004216B
- Authority
- CN
- China
- Prior art keywords
- solution
- reaction
- water
- molecular probe
- fluorescent molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003068 molecular probe Substances 0.000 title claims abstract description 19
- -1 benzoxazine hypochlorous acid Chemical compound 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000243 solution Substances 0.000 claims description 29
- 238000006243 chemical reaction Methods 0.000 claims description 25
- 229920006395 saturated elastomer Polymers 0.000 claims description 14
- 239000012044 organic layer Substances 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 238000004440 column chromatography Methods 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 6
- 238000010791 quenching Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 239000012264 purified product Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims description 3
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 claims description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000011056 potassium acetate Nutrition 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 claims 1
- 230000000171 quenching effect Effects 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 210000000170 cell membrane Anatomy 0.000 abstract description 2
- 230000003013 cytotoxicity Effects 0.000 abstract description 2
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 39
- 239000007850 fluorescent dye Substances 0.000 description 17
- 239000000523 sample Substances 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 7
- 230000004044 response Effects 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000010413 mother solution Substances 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000003896 Myeloperoxidases Human genes 0.000 description 2
- 108090000235 Myeloperoxidases Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- YLRBJYMANQKEAW-UHFFFAOYSA-N 1-bromo-4-(bromomethyl)benzene Chemical compound BrCC1=CC=C(Br)C=C1 YLRBJYMANQKEAW-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RWSXRVCMGQZWBV-PHDIDXHHSA-N L-Glutathione Natural products OC(=O)[C@H](N)CCC(=O)N[C@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-PHDIDXHHSA-N 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- AOADSHDCARXSGL-ZMIIQOOPSA-M alkali blue 4B Chemical compound CC1=CC(/C(\C(C=C2)=CC=C2NC2=CC=CC=C2S([O-])(=O)=O)=C(\C=C2)/C=C/C\2=N\C2=CC=CC=C2)=CC=C1N.[Na+] AOADSHDCARXSGL-ZMIIQOOPSA-M 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 description 1
- 238000012984 biological imaging Methods 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- VCJZTATVUDMNLU-UHFFFAOYSA-N dibromomethylbenzene Chemical compound BrC(Br)C1=CC=CC=C1 VCJZTATVUDMNLU-UHFFFAOYSA-N 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/38—[b, e]-condensed with two six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0028—Oxazine dyes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1033—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
Abstract
The invention discloses a preparation method and application of a novel benzoxazine hypochlorous acid fluorescent molecular probe, and the chemical structural formula is as follows:
Description
Technical Field
The invention belongs to the technical field of analytical chemistry, and relates to a preparation method and application of a novel benzoxazine hypochlorous acid fluorescent molecular probe.
Background
Hypochlorous acid (Hypochlorous acid, HOCl) is produced by the catalysis of hydrogen peroxide and chloride ions by Myeloperoxidase (MPO), an important member of the active oxygen family in vivo, playing an important role in physiological and pathological processes. HOCl is strongly oxidative and kills pathogens, thus contributing to host defense, and endogenous HClO can also serve as a signal to activate caspases and mediate apoptosis. However, excessive HClO in the body causes oxidative damage to biomolecules such as nucleic acids, proteins and lipids, which may lead to various diseases such as cardiovascular diseases, atherosclerosis, osteoarthritis, rheumatoid arthritis and lung injury. Thus, monitoring the concentration level of HClO in cells is of great importance for further understanding of its biological role and early diagnosis of related diseases.
In recent years, electrochemical, colorimetric, chemiluminescent, fluorescent imaging and other methods have been applied to the detection of HClO. The fluorescence imaging method has the advantages of high sensitivity, strong specificity, short response time, real-time monitoring and the like, and is widely applied to detection and imaging of HClO. CN 110357869A reports that a fluorescent molecular probe based on naphthalimide parent nucleus and used for HClO specific detection has good chemical and light stability. However, the probe gradually reduces fluorescence at 510 and nm after being in response to HClO, and shows a "Turn-OFF" type fluorescence response, is easily affected by environment, and has a large detection error. CN 109400563A reports a fluorescent probe CoPh-ClO, which allows for rapid detection of HClO specificity, as a specific indicator of HClO presence in aqueous solutions and within biological cells. However, the probe has the problem of short emission wavelength (510-nm) and is easily interfered by background fluorescence during intracellular imaging. CN 109942504A reports that a probe molecule with HClO response is constructed by using near infrared fluorophore alkali blue as a fluorescent molecular skeleton, and uses the transition between a reduced state and an oxidized state to realize fluorescence opening, and when HClO is added, the probe exhibits fluorescence enhancement at 670 nm, so that detection of HClO can be realized. However, the poor water solubility of this probe results in poor biocompatibility, limiting its further use for in vivo detection of HClO. Therefore, the development of the red light-emitting fluorescent molecular probe with high sensitivity, high specificity and good water solubility has very important significance for realizing the detection of the HClO in the environment and organisms.
Disclosure of Invention
Aiming at the defects of the existing HClO fluorescent molecular probe, the invention aims to provide the HClO fluorescent molecular probe which has good water solubility, high specificity and red light emission.
The second object of the present invention is to provide a method for efficiently preparing the fluorescent molecular probe.
The third object of the present invention is to provide the application of the fluorescent molecular probe in detecting HClO in water solution and organism.
In order to achieve the above object, the present invention provides a fluorescent molecular probe having the structure of formula I:
i is a kind of
The preparation method of the fluorescent probe preferably comprises the following steps:
dissolving benzoxazine in anhydrous DMF solution, 0 o Adding 60% NaH solution and bromobenzyl bromide in portions under the condition of C, stirring at room temperature to finish the reaction, and cooling to 0 o C, dropwise adding water to quench the reaction, and respectively using water and saturated NaHCO 3 The solution and saturated saline are extracted, the organic layers are combined, dried and concentrated, and the white product can be obtained after column chromatography purification. Dissolving the purified product in CHCl 3 The solution was added with NBS in portions and the reaction was stirred at room temperature to completion. Taking down the reaction, adding water dropwise to quench the reaction, and respectively using water and saturated NaHCO 3 The solution and saturated brine are extracted, the organic layers are combined, dried and concentrated, and ethyl acetate is recrystallized to obtain white solid. The purified product, 4-nitrophenol, potassium acetate and Pd (dppf) Cl 2 DCM was dissolved in anhydrous DMF solution and heated to reflux under argon until the reaction was complete. Taking down the reaction, cooling to room temperature, and respectively using water and saturationAnd NaHCO 3 Extracting the solution and saturated saline, combining the organic layers, drying, concentrating, and purifying by column chromatography to obtain a white product. The purified product and SnCl 2 ·2H 2 O is added to CH 3 OH, concentrated HCl and H 2 In the mixed solution of O, stirring at room temperature until the reaction is complete, using saturated Na 2 CO 3 The pH of the solution is adjusted to be alkaline, and water and saturated NaHCO are respectively used 3 Extracting the solution and saturated saline, combining organic layers, drying, concentrating, and purifying by column chromatography to obtain the target molecular probe.
The synthesis of the invention is as follows:
the invention provides an application of the fluorescent probe, which can be applied to detection of HClO. The detection mechanism of the probe is as follows:
compared with the prior art, the technical scheme of the invention has the beneficial technical effects that:
the fluorescent molecular probe for detecting HClO has the following advantages:
(1) The fluorescent probe has the advantages of stable and high chemical property and high optical stability, and has no autoxidation and no bleaching phenomenon;
(2) The fluorescent probe has the advantages of good water solubility, quick response and high specificity, can avoid the interference of other objects to be detected, is beneficial to the quick detection of HClO in the environment, and has stronger practical application value in the field of environmental science;
(3) The probe has stronger red light emission, can effectively avoid the interference of biological autofluorescence, has good cell membrane permeability and small cytotoxicity, can be used for the biological imaging of HClO, and has stronger practical application value in the field of life science.
Drawings
FIG. 1 is a graph showing the emission spectrum of fluorescence intensity of a fluorescent probe according to HClO concentration in the practice of the present invention;
FIG. 2 is a graph showing the selectivity of fluorescent probes for HClO in the practice of the present invention;
FIG. 3 is a fluorescence confocal image of fluorescent probes in HeLa cells in the practice of the present invention.
Detailed Description
The following embodiments are intended to further illustrate the invention and are not limiting thereof.
Example 1
Synthesis of Compound 1:
benzoxazine (1830 mg,10 mmol) was dissolved in 25 mL anhydrous DMF at 0 o 60% NaH solution (4727 mg,12 mmol) was added in portions at C, and after stirring continued for 10 minutes p-bromobenzyl bromide (3000 mg,12 mmol) was added in portions and the reaction stirred at room temperature to completion. Cooling to 0deg.C, adding dropwise water to quench the reaction, respectively adding water and saturated NaHCO 3 The solution and saturated brine were extracted, and the organic layers were combined, dried over anhydrous magnesium sulfate, concentrated, and purified by column chromatography to give the white product 2899 mg in 82.3% yield.
Synthesis of Compound 2:
compound 1 (2817.6 mg,8 mmol) was dissolved in 25 mL HCl 3 To the solution, NBS (2854.6 mg,9.08mmol) was added in portions, and the reaction was stirred at room temperature until the end. Taking down the reaction, adding water dropwise to quench the reaction, and respectively using water and saturated NaHCO 3 The solution and saturated brine were extracted, and the organic layers were combined, dried over anhydrous magnesium sulfate, concentrated and dried to give a crude product, which was recrystallized from ethyl acetate to give 2044.1 mg as a white solid in 50.1% yield.
Synthesis of Compound 3:
compound 2 (2040 mg,4 mmol), 4-nitrophenol (2225.6 mg,16 mmol), potassium acetate (2348.7 mg,24 mmol) and Pd (dppf) Cl 2 DCM (2817.7 mg,0.4 mmol) was dissolved in 7 mL anhydrous DMF and heated to reflux under argon until the reaction was complete. Taking down the reaction, cooling to room temperature, and respectively using water and saturated NaHCO 3 Extracting the solution with saturated saline, mixing organic layers, drying with anhydrous magnesium sulfate, concentrating, drying, purifying by column chromatography to obtain white product 1128.2 mg,the yield was 41.2%. 1 H NMR (300 MHz, CDCl3)δ8.82 (d, 6H,J=7.8 Hz), 7.43 (d, 2H,J=8.3 Hz), 7.28 (d, 2H,J=8.3 Hz), 7.21 (d, 6H,J=7.8 Hz), 6.66 (s, 2 H), 6.52-6.51(m, 4H), 4.32 (s, 2H)。
Synthesis of target molecular probes:
to compound 3 (684.6 mg,1 mmol) and SnCl 2 ·2H 2 O (3371.4 mg,15 mmol) was added to 16 mLCH 3 OH: concentrated HCl: h 2 The mixed solution of o=3:2:3 was stirred at room temperature until the reaction was complete. After the reaction, saturated Na was used 2 CO 3 The pH of the solution is adjusted to be alkaline, and water and saturated NaHCO are respectively used 3 The solution and saturated brine were extracted, and the organic layers were combined, dried over anhydrous magnesium sulfate, and concentrated to dryness. After purification by column chromatography, the target molecular probe 319.3. 319.3 mg was obtained in 53.7% yield. 1 H NMR (300 MHz, CDCl3)δ7.35 (d, 2H,J=8.4 Hz), 7.30 (d, 2H,J=8.4 Hz), 7.21 (d, 6H,J=7.8 Hz), 6.76-6.73 (m, 12H), 6.65 (s, 2H), 6.53-6.50 (m, 4H), 6.27 (s, 6H), 4.30 (s, 2 H)。HRMS (ESI):calculated [M+H] + : 595.22670, found [M+H] + : 595.21371。
Example 2
Preparation of fluorescent Probe stock solution
Accurately weighing the product with purity of above 99%, transferring into 50 mL volumetric flask, and adding CH at room temperature 3 CN solution is completely dissolved, and the volume is fixed to the scale mark, so that probe mother liquor with the concentration of 1 mM is obtained. During the test, 20. Mu.L of the above solution was measured with a microsyringe each time and dissolved in the test system so that the total volume of each test was 2 mL, at which time the concentration of the fluorescent probe was 10. Mu.M.
Example 3
Preparation of HClO mother liquor
HClO was prepared as a stock solution with 5 mL different concentration gradients (0.1 mM, 0.3 mM, 0.6 mM, 1.0 mM, 1.5 mM, 2.0 mM, 3.0 mM, 4.0 mM) with PBS buffer. The rest substances to be tested are prepared into mother solution with concentration of 3 mM by using PBS buffer solution.
Example 4
Relationship between fluorescence intensity of fluorescent probe and HClO concentration
Measuring 4.900 mL of PBS buffer solution, dissolving 50 mu L of probe mother solution with the concentration of 1 mM, and then transferring 50 mu L of HClO mother solution with different concentrations into the solution so that the final concentration of the probe of the whole detection system is 10 mu M and Hg 2+ The concentration of (C) is 1. Mu.M, 3. Mu.M, 6. Mu.M, 10. Mu.M, 15. Mu.M, 20. Mu.M, 30. Mu.M, 40. Mu.M, respectively. After incubation at room temperature for 20 min, the fluorescence spectra of the different systems were measured in cuvettes of 10 mm, respectively (fig. 1). The results showed that as the HClO concentration was increased, the fluorescence emission intensity of the system was increased at 590 nm.
Example 5
Selectivity of fluorescent probe for HClO detection
50. Mu.L of probe stock solution with a concentration of 1 mM was dissolved in 4.900 mL of PBS buffer solution, and 50. Mu.L of O with a concentration of 3 mM was removed 2 -、NO、H 2 O 2 T-butyl peroxy alcohol, NO 3 -, L-cysteine, L-glutathione, fe 3+ The mother solutions were added to the system and incubated at room temperature for 20 min, and their fluorescence spectra were measured, respectively, and the fluorescence intensity values of 590 nm (FIG. 2) were recorded. As shown in the figure, the results show that the fluorescence of the fluorescent probe is significantly enhanced when only HClO is added, and that no or only weak fluorescence changes are observed when other test metal ions or molecules are added. The fluorescent probe has good selectivity.
Example 6
Response of fluorescent probes to HClO in cells
Adding 10 μm fluorescent probe solution into HeLa culture medium, and standing at 37 o C, 5% CO 2 After incubation in an incubator for 30 minutes, the probe molecules that did not enter the cells were removed by washing three times with 0.1M PBS buffer (10 mm, ph=7.4), then the medium was changed, and further incubated with HClO buffer (25 μm) for 30 minutes, washed three times with 0.1M PBS buffer (10 mm, ph=7.4), and the fluorescence change was observed under a fluorescence microscope, and the results are shown in fig. 3. Experiments show that the probe enters the cell bodyThe needle molecule reacts with HClO to emit intense red fluorescence, so that the fluorescent probe has good imaging effect on HClO in cells and can be used for detecting HClO in organisms.
While the specific embodiments of the invention have been described above with reference to the drawings, it is not intended to limit the scope of the invention, and various modifications or variations which would be apparent to those skilled in the art from the disclosure herein without the benefit of the teachings of this invention are within the scope of the invention.
Claims (2)
1. The benzoxazine hypochlorous acid fluorescent molecular probe is characterized by having a structure shown in a formula I:
2. the method for preparing the benzoxazine hypochlorous acid fluorescent molecular probe according to claim 1, which is characterized in that: dissolving benzoxazine in anhydrous DMF solution, adding 60% NaH solution and benzyl bromide 4-BnBr in batches at 0 ℃, stirring at room temperature for reaction to finish, cooling to 0 ℃, adding water dropwise for quenching the reaction, and using water and saturated NaHCO respectively 3 Extracting the solution and saturated saline, mixing the organic layers, drying, concentrating, and purifying by column chromatography to obtain white product;
dissolving the purified white product in CHCl 3 Adding NBS into the solution in batches, and stirring at room temperature to finish the reaction;
after the reaction, water is added dropwise to quench the reaction, and water and saturated NaHCO are respectively used 3 Extracting the solution and saturated saline water, combining organic layers, drying, concentrating, and recrystallizing with ethyl acetate to obtain white solid;
white solid, 4-nitrophenol, potassium acetate and Pd (dppf) Cl 2 DCM was dissolved in anhydrous DMF and heated under argon to reflux until reaction was complete;
taking down the reaction, cooling to room temperature, and respectively using water and saturated NaHCO 3 Extracting the solution and saturated saline, mixing the organic layers, drying, concentrating, and purifying by column chromatography to obtain a white product;
the purified product and SnCl 2 ·2H 2 O is added to CH 3 OH, concentrated HCl and H 2 In the mixed solution of O, stirring at room temperature until the reaction is complete, using saturated Na 2 CO 3 The pH of the solution is adjusted to be alkaline, and water and saturated NaHCO are respectively used 3 Extracting the solution and saturated saline, combining the organic layers, drying, concentrating, and purifying by column chromatography to obtain the target fluorescent molecular probe.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911322539.8A CN113004216B (en) | 2019-12-20 | 2019-12-20 | Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911322539.8A CN113004216B (en) | 2019-12-20 | 2019-12-20 | Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113004216A CN113004216A (en) | 2021-06-22 |
CN113004216B true CN113004216B (en) | 2023-10-03 |
Family
ID=76381740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911322539.8A Active CN113004216B (en) | 2019-12-20 | 2019-12-20 | Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113004216B (en) |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102382641A (en) * | 2011-09-22 | 2012-03-21 | 厦门大学 | Fluorescent probe for detecting hypochlorous acid and preparation method thereof |
CN103709122A (en) * | 2013-11-29 | 2014-04-09 | 四川大学 | Antitumor and antifungal compound for treatment |
CN105622632A (en) * | 2014-10-29 | 2016-06-01 | 浙江海森药业有限公司 | Quinolones compound and preparation method thereof |
CN108148055A (en) * | 2018-02-06 | 2018-06-12 | 陕西师范大学 | A kind of D- π-A types organic fluorescence materials and preparation method based on naphthalene |
CN108864350A (en) * | 2018-08-20 | 2018-11-23 | 武汉华星光电半导体显示技术有限公司 | Thermal activation delayed fluorescence material, synthetic method, OLED luminescent device, display device |
CN109384719A (en) * | 2017-08-10 | 2019-02-26 | 湖南超亟化学科技有限公司 | A kind of preparation and application detecting formaldehyde fluorescent molecular probe, synthetic method and test paper |
CN109593192A (en) * | 2018-12-05 | 2019-04-09 | 中国科学院长春应用化学研究所 | Polyarylether/poly arylidene thio-ester and its preparation method and application with thermal activation delayed fluorescence effect |
CN109942504A (en) * | 2019-03-25 | 2019-06-28 | 浙江师范大学 | It is a kind of to detect hypochlorous fluorescent probe molecule and preparation method thereof |
CN113200935A (en) * | 2021-04-26 | 2021-08-03 | 威海海洋生物医药产业技术研究院有限公司 | Fluorescent probe for hypochlorous acid detection and preparation method thereof |
CN113493564A (en) * | 2020-04-07 | 2021-10-12 | 中国科学院长春应用化学研究所 | Organic polymer luminescent material with D-sigma-A structure and preparation method and application thereof |
WO2021261398A1 (en) * | 2020-06-25 | 2021-12-30 | コニカミノルタ株式会社 | Light-emitting nanoparticles and light-emitting labeling material for pathological diagnosis |
CN114945322A (en) * | 2019-11-13 | 2022-08-26 | 传感技术股份有限公司 | Identification of degraded Material |
CN116444509A (en) * | 2023-03-24 | 2023-07-18 | 湖南超亟检测技术有限责任公司 | DCM derivative near infrared fluorescent molecular probe for specifically detecting hypochlorous acid/hypochlorite ions and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100081159A1 (en) * | 2008-09-26 | 2010-04-01 | Lebedeva Irina V | Profiling reactive oxygen, nitrogen and halogen species |
US10048269B2 (en) * | 2014-07-25 | 2018-08-14 | SeLux Diagnostics, Inc. | Assay methods involving dissociable nanoparticles |
-
2019
- 2019-12-20 CN CN201911322539.8A patent/CN113004216B/en active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102382641A (en) * | 2011-09-22 | 2012-03-21 | 厦门大学 | Fluorescent probe for detecting hypochlorous acid and preparation method thereof |
CN103709122A (en) * | 2013-11-29 | 2014-04-09 | 四川大学 | Antitumor and antifungal compound for treatment |
CN105622632A (en) * | 2014-10-29 | 2016-06-01 | 浙江海森药业有限公司 | Quinolones compound and preparation method thereof |
CN109384719A (en) * | 2017-08-10 | 2019-02-26 | 湖南超亟化学科技有限公司 | A kind of preparation and application detecting formaldehyde fluorescent molecular probe, synthetic method and test paper |
CN108148055A (en) * | 2018-02-06 | 2018-06-12 | 陕西师范大学 | A kind of D- π-A types organic fluorescence materials and preparation method based on naphthalene |
WO2020037856A1 (en) * | 2018-08-20 | 2020-02-27 | 武汉华星光电半导体显示技术有限公司 | Thermally activated delayed fluorescence material and synthesis method therefor |
CN108864350A (en) * | 2018-08-20 | 2018-11-23 | 武汉华星光电半导体显示技术有限公司 | Thermal activation delayed fluorescence material, synthetic method, OLED luminescent device, display device |
CN109593192A (en) * | 2018-12-05 | 2019-04-09 | 中国科学院长春应用化学研究所 | Polyarylether/poly arylidene thio-ester and its preparation method and application with thermal activation delayed fluorescence effect |
CN109942504A (en) * | 2019-03-25 | 2019-06-28 | 浙江师范大学 | It is a kind of to detect hypochlorous fluorescent probe molecule and preparation method thereof |
CN114945322A (en) * | 2019-11-13 | 2022-08-26 | 传感技术股份有限公司 | Identification of degraded Material |
CN113493564A (en) * | 2020-04-07 | 2021-10-12 | 中国科学院长春应用化学研究所 | Organic polymer luminescent material with D-sigma-A structure and preparation method and application thereof |
WO2021261398A1 (en) * | 2020-06-25 | 2021-12-30 | コニカミノルタ株式会社 | Light-emitting nanoparticles and light-emitting labeling material for pathological diagnosis |
CN113200935A (en) * | 2021-04-26 | 2021-08-03 | 威海海洋生物医药产业技术研究院有限公司 | Fluorescent probe for hypochlorous acid detection and preparation method thereof |
CN116444509A (en) * | 2023-03-24 | 2023-07-18 | 湖南超亟检测技术有限责任公司 | DCM derivative near infrared fluorescent molecular probe for specifically detecting hypochlorous acid/hypochlorite ions and preparation method and application thereof |
Non-Patent Citations (8)
Title |
---|
Chung-Chieh Lee,等.Synthesis and Properties of Oxygen-Linked N-Phenylcarbazole Dendrimers.Macromolecules.2012,第45卷(第02期),751–765. * |
Jessica Ward,等.Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry--activity-based protein profiling.Biochemistry . .2013,第52卷(第51期),9187-9201. * |
Jianbo Wang.An aggregation-induced emission-based pH-sensitive fluorescent probe for intracellular acidity sensing.RSC Advances .2016,(第06期),25416-25419. * |
刘敏 ; 谭慧龙 ; 刘治国 ; 王维 ; 曾文彬 ; .基于小分子的锌离子荧光分子探针研究进展.有机化学.2013,(第08期),75-87. * |
周明 ; 刘治国 ; 叶秋稷 ; 曾文彬 ; .MRI荧光双模态分子影像探针研究进展.磁共振成像.2013,(第01期),78-82. * |
李海东 ; 樊江莉 ; 彭孝军 ; .识别次氯酸的荧光探针.化学进展.2017,(第01期),29-47. * |
申有名 ; 杨玉芬 ; 谷标 ; .一种基于菲并咪唑的新型次氯酸荧光探针及细胞成像研究.分析测试学报.2020,(第08期),32-37. * |
黄昆.细胞器靶向探针合成及荧光成像研究.中国博士学位论文全文数据库 基础科学辑.2018,(第01期),A006-12. * |
Also Published As
Publication number | Publication date |
---|---|
CN113004216A (en) | 2021-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110563689B (en) | Long-wavelength emission fluorescent probe for specifically detecting cysteine in living cells and preparation method and application thereof | |
CN106632363B (en) | A kind of Mitochondrially targeted Ratio-type hypochlorous acid fluorescence probe and its application | |
CN111205280B (en) | Ratio type fluorescent probe for detecting hypochlorous acid and preparation method and application thereof | |
CN106946902B (en) | A kind of sulfur dioxide near-infrared-two-photon ratio fluorescent probe and preparation method thereof | |
CN108169189B (en) | Ratiometric fluorescent probe responding to sulfur dioxide/sulfite (hydrogen) salt | |
CN110156839B (en) | Mitochondrial-targeted hypochlorite two-photon fluorescence probe and preparation method and application thereof | |
CN109232626B (en) | SO based on difluoro boro coumarin2Ratiometric fluorescent probes | |
CN108117544A (en) | A kind of reversible sulfur dioxide/sulfurous acid(Hydrogen)The fluorescence probe of salt | |
CN113801105B (en) | Mitochondrion targeted peroxynitrite/bisulfite dual-response fluorescent probe | |
CN110078665A (en) | A kind of hypochlorous fluorescence probe of detection of endoplasmic reticulum targeting and application | |
CN110128440A (en) | The fluorescence probe and its preparation method and application of biological thiol in a kind of detection aqueous environment | |
CN107383078B (en) | Phenylboric acid ester compounds and benzoyl peroxide detection kit comprising the compound | |
CN114181204B (en) | Near infrared fluorescent probe for detecting viscosity and preparation and application thereof | |
CN110498758B (en) | Near-infrared fluorescent probe for identifying glutathione and preparation and application thereof | |
CN114105927B (en) | Construction of benzopyran nitrile fluorescent molecular probe and in-vitro diagnosis application thereof | |
CN110818734A (en) | Fluorescent probe with double-ratio recognition function for hydrogen peroxide and hypochlorous acid | |
CN107286173A (en) | Rhodol analog derivatives and its preparation method and application | |
CN113004258B (en) | Preparation method and application of hydrogen sulfide ratio type fluorescent molecular probe based on ESIPT effect | |
CN111778014A (en) | Beta-galactosidase near-infrared fluorescent probe and preparation method and application thereof | |
CN110878085B (en) | Rapid high-selectivity hypobromous acid fluorescent probe, preparation method and application | |
CN108383774A (en) | It is a kind of based on the cysteine fluorescence probe of end group acetylenic ketone and its preparation and application | |
CN113004216B (en) | Preparation method and application of benzoxazine hypochlorous acid fluorescent molecular probe | |
CN115232152B (en) | Fluorescent probe for detecting hypochlorous acid and preparation method and application thereof | |
CN109608495B (en) | Compound for detecting HNO and preparation method and application thereof | |
CN115594672A (en) | Methylene blue near-infrared fluorescent probe and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211014 Address after: 410205 room 901, building 4, haipingyuan Park, No. 229, Guyuan Road, high tech Development Zone, Changsha, Hunan Applicant after: Hunan Chaoji Testing Technology Co.,Ltd. Address before: 410205 building C11, jinruilugu Science Park, 28 Lutian Road, high tech Development Zone, Changsha City, Hunan Province Applicant before: HUNAN CHAOJI CHEMICAL TECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |